Lenalidomide for Second-line Treatment of Advanced Hepatocellular Cancer : A Brown University Oncology Group Phase II Study
Surgical Treatment of Advanced Gallbladder Cancer
Adjuvant Chemoradiation Plus Intraoperative Radiotherapy Versus Adjuvant Chemoradiation Alone in Patients With Locally Advanced Rectal Cancer
Postoperative Treatment With Docetaxel, Cisplatin, and Capecitabine (DCX) and Chemoradiotherapy (CRT) With Capecitabine for Resected Gastric Adenocarcinoma
Can Elderly Patients With Newly Diagnosed Glioblastoma be Enrolled in Radiochemotherapy Trials?
Efficacy of Rechallenge Chemotherapy in Patients With Sensitive Relapsed Small Cell Lung Cancer
KRAS Mutation as the Biomarker of Response to Chemotherapy and EGFR-TKIs in Patients With Advanced Non–Small Cell Lung Cancer : Clues For Its Potential Use in Second-Line Therapy Decision Making
Tumor Volume Change With Stereotactic Body Radiotherapy (SBRT) for Early-stage Lung Cancer : Evaluating the Potential for Adaptive SBRT
Fast Neutron Radiotherapy in the Treatment of Malignant Pleural Mesothelioma
Outcomes of Small Cell Lung Cancer Patients Treated With Cisplatin-Etoposide Versus Carboplatin-Etoposide
Adjuvant Versus Salvage Radiation Therapy for Prostate Cancer Patients With Adverse Pathologic Features : Comparative Analysis of Long-term Outcomes
Phase II Study of Nab-Paclitaxel and Bevacizumab as First-line Therapy for Patients with Unresectable Stage III and IV Melanoma
Contribution of Involved-field Radiotherapy to Survival in Patients With Relapsed or Refractory Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplantation
Combined Neoadjuvant Chemotherapy With Bevacizumab Improves Pathologic Complete Response in Patients With Hormone Receptor Negative Operable or Locally Advanced Breast Cancer
Treatment of Chest Wall Sarcomas : A Single-institution Experience Over 20 Years
Radiation Therapy for Mucosal Melanoma of the Head and Neck
Immune-priming of the Tumor Microenvironment by Radiotherapy : Rationale for Combination With Immunotherapy to Improve Anticancer Efficacy
Surgery for Li Fraumeni Syndrome : Pushing the Limits of Surgical Oncology
Gene Expression Profiling for Early-stage NSCLC
MUC1 as a Potential Target in Anticancer Therapies
Role of Radiation Therapy as Immune Activator in the Era of Modern Immunotherapy for Metastatic Malignant Melanoma